New tacrolimus tablet studied for kidney transplant patients
NCT ID NCT04102943
First seen Apr 16, 2026 · Last updated Apr 28, 2026 · Updated 1 time
Summary
This study looked at how a tacrolimus tablet (TacroBell) works in 128 kidney transplant patients. The goal was to measure drug levels in the blood and see how well patients tolerated the medicine. Tacrolimus is an immunosuppressant taken long-term to prevent organ rejection, so this is about managing the condition after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.